OA10811A - Novel fused pyrrolecarboxamides a new class of gaba brain receptor ligands - Google Patents

Novel fused pyrrolecarboxamides a new class of gaba brain receptor ligands Download PDF

Info

Publication number
OA10811A
OA10811A OA9800115A OA9800115A OA10811A OA 10811 A OA10811 A OA 10811A OA 9800115 A OA9800115 A OA 9800115A OA 9800115 A OA9800115 A OA 9800115A OA 10811 A OA10811 A OA 10811A
Authority
OA
OAPI
Prior art keywords
compound according
oxo
hydrogen
tetrahydro
carboxamide
Prior art date
Application number
OA9800115A
Other languages
English (en)
Inventor
Pamela Albaugh
Gang Liu
Kenneth Shaw
Alan Hutchison
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Publication of OA10811A publication Critical patent/OA10811A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Indole Compounds (AREA)
OA9800115A 1996-01-19 1998-07-15 Novel fused pyrrolecarboxamides a new class of gaba brain receptor ligands OA10811A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/588,711 US5804686A (en) 1996-01-19 1996-01-19 fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Publications (1)

Publication Number Publication Date
OA10811A true OA10811A (en) 2001-07-05

Family

ID=24354983

Family Applications (1)

Application Number Title Priority Date Filing Date
OA9800115A OA10811A (en) 1996-01-19 1998-07-15 Novel fused pyrrolecarboxamides a new class of gaba brain receptor ligands

Country Status (26)

Country Link
US (2) US5804686A (ja)
EP (1) EP1019372B1 (ja)
JP (1) JP2000503321A (ja)
KR (1) KR100490108B1 (ja)
CN (1) CN1209805A (ja)
AP (1) AP1015A (ja)
AT (1) ATE322480T1 (ja)
AU (1) AU1746697A (ja)
BG (1) BG102634A (ja)
BR (1) BR9707051A (ja)
CA (1) CA2243317C (ja)
CZ (1) CZ215498A3 (ja)
DE (1) DE69735647T2 (ja)
ES (1) ES2263170T3 (ja)
HU (1) HUP9901018A3 (ja)
IL (1) IL125391A (ja)
IS (1) IS4798A (ja)
MX (1) MX9805701A (ja)
NO (1) NO312670B1 (ja)
NZ (1) NZ330861A (ja)
OA (1) OA10811A (ja)
PL (1) PL327936A1 (ja)
RU (1) RU2167151C2 (ja)
SK (1) SK94398A3 (ja)
UA (1) UA49001C2 (ja)
WO (1) WO1997026243A1 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750702A (en) * 1993-10-27 1998-05-12 Neurogen Corporation Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
US6211365B1 (en) 1996-01-19 2001-04-03 Neurogen Corporation Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
WO1997034870A1 (en) 1996-03-22 1997-09-25 Neurogen Corporation Certain fused pyrrolecarboxamides as gaba brain receptor ligands
US5723462A (en) * 1996-04-26 1998-03-03 Neurogen Corporation Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
GT199800179A (es) * 1997-11-13 2000-05-02 Procedimiento de sintesis de pirrol amidas.
YU27300A (sh) * 1997-11-13 2002-10-18 Pfizer Products Inc. Postupak sinteze pirolnih amida
WO1999043660A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands
GB9812038D0 (en) 1998-06-04 1998-07-29 Merck Sharp & Dohme Therapeutic compound
WO2000012492A1 (en) * 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
CZ2002614A3 (cs) * 1999-08-31 2002-08-14 Neurogen Corporation Kondenzované pyrrolkarboxamidy jako ligandy mozkových GABA-receptorů
US20050014939A1 (en) * 1999-08-31 2005-01-20 Neurogen Corporation Fused pyrrolecarboxamides: GABA brain receptor ligands
AU2001264932A1 (en) * 2000-05-26 2001-12-11 Neurogen Corporation Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
WO2002020492A1 (en) * 2000-09-06 2002-03-14 Neurogen Corporation Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
EP1326831A1 (en) * 2000-09-06 2003-07-16 Neurogen Corporation Substituted fused pyrroleimines and pyrazoleimines
CA2430841A1 (en) * 2000-12-04 2002-06-13 Pfizer Products Inc. Synthesis of fused pyrrolecarboxamides
JP2005525333A (ja) * 2002-02-07 2005-08-25 ニューロジェン コーポレイション 置換縮合ピラゾールカルボン酸アリールアミド及び関連化合物
ATE333455T1 (de) 2002-05-17 2006-08-15 Neurogen Corp Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
JP5373613B2 (ja) 2006-10-16 2013-12-18 バイオノミクス リミテッド 新規な抗不安薬化合物
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CR20200540A (es) 2010-08-31 2021-03-16 Meiji Seika Pharma Co Ltd DERIVADOS DE AMINA PARA EL CONTROL DE PLAGAS (Divisional 2019-0244)
US9023848B2 (en) 2011-03-02 2015-05-05 Bionomics Limited Small-molecules as therapeutics
WO2012151640A1 (en) 2011-05-12 2012-11-15 Bionomics Limited Methods for preparing naphthyridines

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455943A (en) * 1966-10-21 1969-07-15 American Cyanamid Co Certain 5,8-dihydro-beta-carbolines
US4075343A (en) * 1976-09-13 1978-02-21 Pfizer Inc. Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof
DE3029980A1 (de) * 1980-08-08 1982-03-11 Boehringer Mannheim Gmbh, 6800 Mannheim Indolderivate und verfahren zu ihrer herstellung
JPS57123180A (en) * 1980-12-17 1982-07-31 Schering Ag 3-substituted beta-carboline, manufacture and psychotropic drug containing same
DE3147276A1 (de) * 1981-11-28 1983-06-09 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von indolderivaten, deren verwendung als wertvolle zwischenprodukte und neue 4-hydroxyindole
DE3246932A1 (de) * 1982-12-16 1984-06-20 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte 5h-pyrimido(5,4-b)indole
DE3335323A1 (de) * 1983-09-27 1985-04-04 Schering AG, 1000 Berlin und 4709 Bergkamen Substituierte ss-carboline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
GB8429739D0 (en) * 1984-11-24 1985-01-03 Fbc Ltd Fungicides
DE3535927A1 (de) * 1985-10-04 1987-04-09 Schering Ag 3-vinyl- und 3-ethinyl-ss-carbolinderivate, ihre herstellung und ihre verwendung als arzneimittel
CA2091986C (en) * 1990-10-09 1995-11-28 Andrew Thurkauf Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands
US5243049A (en) * 1992-01-22 1993-09-07 Neurogen Corporation Certain pyrroloquinolinones: a new class of GABA brain receptor ligands
AU3443493A (en) * 1992-02-19 1993-09-13 Upjohn Company, The 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity
US5266698A (en) * 1992-04-30 1993-11-30 Neurogen Corporation Certain aryl and cycloalkyl fused imidazopyrazinediones; a new class of GABA brain receptor ligands
WO1994017095A1 (en) * 1993-01-29 1994-08-04 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
US5484944A (en) * 1993-10-27 1996-01-16 Neurogen Corporation Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands
US5804686A (en) * 1996-01-19 1998-09-08 Neurogen Corporation fused pyrrolecarboxamides; a new class of GABA brain receptor ligands

Also Published As

Publication number Publication date
IL125391A0 (en) 1999-03-12
IL125391A (en) 2004-07-25
KR19990077300A (ko) 1999-10-25
HUP9901018A3 (en) 1999-11-29
DE69735647D1 (de) 2006-05-18
MX9805701A (es) 1998-11-30
CZ215498A3 (cs) 1999-09-15
CA2243317C (en) 2007-09-25
ES2263170T3 (es) 2006-12-01
US5804686A (en) 1998-09-08
PL327936A1 (en) 1999-01-04
AP1015A (en) 2001-09-28
ATE322480T1 (de) 2006-04-15
EP1019372B1 (en) 2006-04-05
BG102634A (en) 1999-08-31
BR9707051A (pt) 1999-07-20
DE69735647T2 (de) 2007-05-03
AU1746697A (en) 1997-08-11
SK94398A3 (en) 1999-02-11
JP2000503321A (ja) 2000-03-21
US6080873A (en) 2000-06-27
NZ330861A (en) 2000-03-27
NO312670B1 (no) 2002-06-17
WO1997026243A1 (en) 1997-07-24
CN1209805A (zh) 1999-03-03
CA2243317A1 (en) 1997-07-24
NO983315D0 (no) 1998-07-17
IS4798A (is) 1998-07-16
UA49001C2 (uk) 2002-09-16
HUP9901018A2 (hu) 1999-07-28
RU2167151C2 (ru) 2001-05-20
EP1019372A1 (en) 2000-07-19
AP9801297A0 (en) 1998-09-30
KR100490108B1 (ko) 2005-11-25
NO983315L (no) 1998-09-03

Similar Documents

Publication Publication Date Title
OA10811A (en) Novel fused pyrrolecarboxamides a new class of gaba brain receptor ligands
US5608079A (en) Certain fused pyrrolecarboxanilides; a new class of GABA brain receptor ligands
US5750702A (en) Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands
WO1997026243A9 (en) Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
US6353109B2 (en) Certain fused pyrrolecarboxamides; a new class of GABA brain receptor
EP0555391B1 (en) Certain imidazoquinoxalines; a new class of gaba brain receptor ligands
US5723462A (en) Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands
WO1998002420A9 (en) Certain fused pyrrolecarboxanilides; a new class of gaba brain receptor ligands
US6211365B1 (en) Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
US6177569B1 (en) Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands
US5637724A (en) Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
US5637725A (en) Substituted aryl and cycloalkyl imidazolones; a new class of GABA brain receptor ligands
AU729634B2 (en) Certain fused pyrrolecarboxanilides: A new class of GABA brain receptor ligands
CA2249562C (en) Certain fused pyrrolecarboxamides as gaba brain receptor ligands
AU6808000A (en) Novel fused pyrrolecarboxamides; a new class of gaba brain receptor ligands
MXPA98007730A (en) Certain pirrolcarboxamidas fusionadas, a new lingandos of the receiver gaba del cere
CA2341531A1 (en) Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands